Cargando…
C-Met as a Key Factor Responsible for Sustaining Undifferentiated Phenotype and Therapy Resistance in Renal Carcinomas
C-Met tyrosine kinase receptor plays an important role under normal and pathological conditions. In tumor cells’ overexpression or incorrect activation of c-Met, this leads to stimulation of proliferation, survival and increase of motile activity. This receptor is also described as a marker of cance...
Autores principales: | Marona, Paulina, Górka, Judyta, Kotlinowski, Jerzy, Majka, Marcin, Jura, Jolanta, Miekus, Katarzyna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468372/ https://www.ncbi.nlm.nih.gov/pubmed/30909397 http://dx.doi.org/10.3390/cells8030272 |
Ejemplares similares
-
Resistance to tyrosine kinase inhibitors promotes renal cancer progression through MCPIP1 tumor-suppressor downregulation and c-Met activation
por: Marona, Paulina, et al.
Publicado: (2022) -
Fatty Acids and a High-Fat Diet Induce Epithelial–Mesenchymal Transition by Activating TGFβ and β-Catenin in Liver Cells
por: Kwapisz, Oliwia, et al.
Publicado: (2021) -
MCPIP1 inhibits Wnt/β-catenin signaling pathway activity and modulates epithelial-mesenchymal transition during clear cell renal cell carcinoma progression by targeting miRNAs
por: Gorka, Judyta, et al.
Publicado: (2021) -
Activity of MCPIP1 RNase in tumor associated processes
por: Miekus, Katarzyna, et al.
Publicado: (2019) -
MCPIP1 contributes to clear cell renal cell carcinomas development
por: Ligeza, Janusz, et al.
Publicado: (2017)